Johns Hopkins HIV Guide
Primaquine
INDICATIONS
FDA
FDA
- Malaria treatment or prevention of relapses caused by Plasmodium vivax. Also effective against gametocytes of P. falciparum.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of Pneumocystis jirovecii pneumonia (PCP) (in combination with clindamycin).
- Prevention and treatment of uncomplicated P. ovale malaria
- Presumptive antirelapse therapy for P. ovale malaria
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 11, 2017
Citation
Smith, Janessa, and Paul A Pham. "Primaquine." Johns Hopkins HIV Guide, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545170/all/Primaquine.
Smith J, Pham PA. Primaquine. Johns Hopkins HIV Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545170/all/Primaquine. Accessed September 25, 2023.
Smith, J., & Pham, P. A. (2017). Primaquine. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545170/all/Primaquine
Smith J, Pham PA. Primaquine [Internet]. In: Johns Hopkins HIV Guide. ; 2017. [cited 2023 September 25]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545170/all/Primaquine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Primaquine
ID - 545170
A1 - Smith,Janessa,Pharm.D. BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/12/11/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545170/all/Primaquine
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
